Carisoprodol is metabolized within the liver by CYP2C19 to form meprobamate [see Scientific PHARMACOLOGY]. Co-administration of CYP2C19 inhibitors, which include omeprazole or fluvoxamine, with SOMA could bring about greater exposure of carisoprodol and lessened exposure of meprobamate. Would you like to look at your HealthSavvy Plans now, or keep on https://leanax075icw6.blogars.com/profile